Used as a key intermediate in Suzuki-Miyaura cross-coupling reactions for the synthesis of pharmaceuticals and biologically active compounds. Its pyridine-boronic acid structure enables efficient carbon-carbon bond formation, particularly in drug discovery and development of kinase inhibitors. Commonly employed in the preparation of complex heterocyclic systems found in medicinal agents and agrochemicals. The methoxymethyl group enhances solubility and can act as a protecting group or a handle for further functionalization. Valued in research settings for building blocks in organic synthesis, especially in creating libraries of compounds for biological screening.